Login / Signup

Blood MAPT expression and methylation status in Alzheimer's disease.

Hiroaki MoriYuta YoshinoMariko UenoYu FunahashiHiroshi KumonYuki OzakiKiyohiro YamazakiShinichiro OchiJun-Ichi IgaShu-Ichi Ueno
Published in: PCN reports : psychiatry and clinical neurosciences (2022)
mRNA expression. Further studies are needed to explore blood biomarkers that can discriminate AD patients from controls.
Keyphrases
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • poor prognosis
  • prognostic factors
  • cognitive decline
  • genome wide
  • patient reported outcomes
  • long non coding rna
  • case control